Literature DB >> 31423246

MicroRNA-758 inhibits cervical cancer cell proliferation and metastasis by targeting HMGB3 through the WNT/β-catenin signaling pathway.

Tao Song1, Xinghua Hou2, Bing Lin1.   

Abstract

Cervical cancer (CC) remains a highly prevalent cancer and cause of mortality amongst women worldwide. miR-758 has been demonstrated to be associated with tumorigenesis by controlling the expression of oncogenic or tumor suppressor genes. However, the function and mechanisms of miR-758 in CC have not been well illustrated. The present study aimed to dissect the effect of miR-758 on the proliferation, migration and invasion of CC cells and determine the potential underlying molecular mechanism of these effects. qPCR results revealed that the expression of miR-758 was significantly decreased in CC tissues and cell lines compared with that in normal tissues and normal cells. Results of CCK-8, colony formation and Transwell assays revealed that miR-758 overexpression markedly decreased cell viability, proliferation, invasion and migration. However, miR-758 inhibitors significantly increased viability, proliferation, invasion and migration. In the mechanism study, we demonstrated that high mobility group box 3 (HMGB3) was a direct target of miR-758, and HMGB3 overexpression rescued the viability, proliferation, invasion and migration of HeLa cells reduced by an miR-758 mimic. It was demonstrated that HMGB3 regulated the WNT/β-catenin signaling pathway under miR-758 regulation. In summary, these observations suggested that miR-758 is a tumor suppressor gene that can inhibit the metastatic phenotype of CC cells by negatively regulating HMGB3, which may present a path to novel therapeutic stratagems for CC therapy.

Entities:  

Keywords:  HMGB3; WNT/β-catenin signaling pathway; cervical cancer; microRNA-758; migration and invasion; proliferation

Year:  2019        PMID: 31423246      PMCID: PMC6607054          DOI: 10.3892/ol.2019.10470

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  18 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

2.  Increased expression of HMGB3: a novel independent prognostic marker of worse outcome in patients with esophageal squamous cell carcinoma.

Authors:  Jing Gao; Zhengzhi Zou; Jing Gao; Haifang Zhang; Zhicai Lin; Yaya Zhang; Xianyang Luo; Changhua Liu; Jingdun Xie; Chengfu Cai
Journal:  Int J Clin Exp Pathol       Date:  2015-01-01

3.  Cancer statistics, 2014.

Authors:  Rebecca Siegel; Jiemin Ma; Zhaohui Zou; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2014-01-07       Impact factor: 508.702

4.  Hmgb3: an HMG-box family member expressed in primitive hematopoietic cells that inhibits myeloid and B-cell differentiation.

Authors:  Michael J Nemeth; David J Curtis; Martha R Kirby; Lisa J Garrett-Beal; Nancy E Seidel; Amanda P Cline; David M Bodine
Journal:  Blood       Date:  2003-04-24       Impact factor: 22.113

Review 5.  Clinical Significance and Prognosis Value of Wnt Signaling Pathway in Cervical Cancer.

Authors:  Afsane Bahrami; Malihe Hasanzadeh; Soodabeh ShahidSales; Zohre Yousefi; Sima Kadkhodayan; Marjaneh Farazestanian; Mona Joudi Mashhad; Masoumeh Gharib; Seyed Mahdi Hassanian; Amir Avan
Journal:  J Cell Biochem       Date:  2017-05-03       Impact factor: 4.429

Review 6.  Cancer screening in the United States, 2013: a review of current American Cancer Society guidelines, current issues in cancer screening, and new guidance on cervical cancer screening and lung cancer screening.

Authors:  Robert A Smith; Durado Brooks; Vilma Cokkinides; Debbie Saslow; Otis W Brawley
Journal:  CA Cancer J Clin       Date:  2013-02-01       Impact factor: 508.702

Review 7.  MicroRNA and gynecologic cancers.

Authors:  Kohsuke Kanekura; Hirotaka Nishi; Keiichi Isaka; Masahiko Kuroda
Journal:  J Obstet Gynaecol Res       Date:  2016-04-20       Impact factor: 1.730

8.  Prognostic value of HMGB3 expression in patients with non-small cell lung cancer.

Authors:  Ning Song; Bao Liu; Jian-Ling Wu; Rui-Fang Zhang; Lin Duan; Wen-Shu He; Cong-Min Zhang
Journal:  Tumour Biol       Date:  2013-04-23

Review 9.  The complexity of microRNAs in human cancer.

Authors:  Jennifer Y Y Kwan; Pamela Psarianos; Jeff P Bruce; Kenneth W Yip; Fei-Fei Liu
Journal:  J Radiat Res       Date:  2016-03-16       Impact factor: 2.724

Review 10.  Prognostic value of microRNAs in cervical carcinoma: a systematic review and meta-analysis.

Authors:  Shengkang Dai; Yan Lu; Ying Long; Yuehua Lai; Ping Du; Nan Ding; Desheng Yao
Journal:  Oncotarget       Date:  2016-06-07
View more
  17 in total

Review 1.  The role of high mobility group protein B3 (HMGB3) in tumor proliferation and drug resistance.

Authors:  Bin Wen; Ying-Ting Wei; Kui Zhao
Journal:  Mol Cell Biochem       Date:  2021-01-11       Impact factor: 3.396

2.  Long non-coding RNA RP11-480I12.5 promotes cervical carcinoma progression by regulating the Wnt/β-catenin signaling pathway.

Authors:  Li Zhang; Yaqin Li; Lina Sona
Journal:  Oncol Lett       Date:  2019-11-19       Impact factor: 2.967

Review 3.  The associations and roles of microRNA single-nucleotide polymorphisms in cervical cancer.

Authors:  Yaheng Li; Chuanyin Li; Shuyuan Liu; Jia Yang; Li Shi; Yufeng Yao
Journal:  Int J Med Sci       Date:  2021-04-07       Impact factor: 3.738

4.  Hsa_circ_0060937 accelerates non-small cell lung cancer progression via modulating miR-195-5p/HMGB3 pathway.

Authors:  Junfeng Xi; Yunfeng Xi; Zhibin Zhang; Yanhong Hao; Fei Wu; Burong Bian; Guangjun Hao; Weiwei Li; Shuqun Zhang
Journal:  Cell Cycle       Date:  2021-09-01       Impact factor: 5.173

5.  Circular RNA RBM33 contributes to cervical cancer progression via modulation of the miR-758-3p/PUM2 axis.

Authors:  Yi Ding; Xia Yuan; Wenwen Gu
Journal:  J Mol Histol       Date:  2021-01-05       Impact factor: 2.611

6.  Long non-coding RNA X-inactive specific transcript promotes osteosarcoma metastasis via modulating microRNA-758/Rab16.

Authors:  Wei Liu; Qiuping Long; Li Zhang; Dehui Zeng; Bingbing Hu; Wei Zhang; Shengyao Liu; Songyun Deng; Li Chen
Journal:  Ann Transl Med       Date:  2021-05

7.  CircCSNK1G1 Contributes to the Tumorigenesis of Gastric Cancer by Sponging miR-758 and Regulating ZNF217 Expression.

Authors:  Feng Qiang; Jingjing Li
Journal:  Cancer Manag Res       Date:  2021-06-28       Impact factor: 3.989

8.  Circ_0001721 enhances doxorubicin resistance and promotes tumorigenesis in osteosarcoma through miR-758/TCF4 axis.

Authors:  Huapeng Guan; Hao Xu; Jinshui Chen; Weishan Wu; Dongfeng Chen; Yungang Chen; Jianzhong Sun
Journal:  Cancer Cell Int       Date:  2021-07-02       Impact factor: 5.722

9.  MiR-181c-5p Mitigates Tumorigenesis in Cervical Squamous Cell Carcinoma via Targeting Glycogen Synthase Kinase 3β Interaction Protein (GSKIP).

Authors:  Niuniu Li; Chun Cheng; Tieyan Wang
Journal:  Onco Targets Ther       Date:  2020-05-21       Impact factor: 4.147

10.  FOXC1 Regulation of miR-31-5p Confers Oxaliplatin Resistance by Targeting LATS2 in Colorectal Cancer.

Authors:  Hsi-Hsien Hsu; Wei-Wen Kuo; Hui-Nung Shih; Sue-Fei Cheng; Ching-Kuo Yang; Ming-Cheng Chen; Chuan-Chou Tu; Vijaya Padma Viswanadha; Po-Hsiang Liao; Chih-Yang Huang
Journal:  Cancers (Basel)       Date:  2019-10-16       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.